BRIGHT BULB: Researchers advance on ovarian cancer. New clues about how the ovarian cancer tumor works to evade the body’s immune system could offer new leads for treatment and early diagnosis, according to Johns Hopkins researchers. “This really allows us to now target a specific cell type which is the first, we think, to not function properly,” Dr. Jonathan Schneck said.
QUOTE OF THE DAY
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.